CTOs on the Move

Enveric Biosciences

www.enveric.com

 
Enveric Biosciences is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments. Enveric Biosciences has set out with the goal of rigorously testing natural compounds, starting with cannabinoids, to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.enveric.com
  • 4851 Tamiami Trail N Suite 200
    Naples, FL USA 34103
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Enveric Biosciences raised $10M on 01/12/2021
Enveric Biosciences raised $12.8M on 02/09/2021

Similar Companies

Dynarex Corporation

Dynarex Corporation is a Orangeburg, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Humanigen

Humanigen, Inc. (HGEN) is a clinical-stage biopharmaceutical company seeking to transform the treatment of cancers and infectious diseases, including COVID-19, by preventing and treating cytokine storm via its novel, cutting-edge anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody neutralizati.

Oakwood Laboratories

Oakwood Laboratories is a Bedford, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Amador Bioscience

Amador Bioscience, a leading partner for successful new drug development, provides global-standard translational sciences and clinical pharmacology services to clients ranging from cutting-edge biotech start-ups to multinational pharmaceutical companies. Founded in 2018 and supported by prominent institutional investors, Amador Bioscience operates in multiple sites, Pleasanton, CA, Ann Arbor, MI, Germantown, MD, Richmond, VA, Hangzhou and Shanghai, China, and Limburg.

Tavotek Biotherapeutics

Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.